CTHRepealedLegislation
National Health (Botulinum Toxin Program) Special Arrangement 2011 (No. PB 89 of 2011)
16Requirements for administering botulinum toxin pharmaceutical benefit under this Special Arrangement
Start here
Get a plain-English read of 16
Turn the raw legal text into a practical explanation grounded in National Health (Botulinum Toxin Program) Special Arrangement 2011 (No. PB 89 of 2011).
16 Requirements for administering botulinum toxin pharmaceutical benefit under this Special Arrangement
A botulinum toxin pharmaceutical benefit to which this Special Arrangement applies may only be administered: (a) to an eligible patient; and (b) in relation to a condition mentioned for the botulinum toxin pharmaceutical benefit in the column in Schedule 3 headed ‘Treatment Condition’; and (c) by a medical practitioner who is an eligible medical practitioner for the condition.